Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 99425
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.99425
Table 1 Baseline characteristics of 94 patients with bile duct leaks, n (%)
Characteristics
Overall (n = 94)
< 3 weeks (n = 50)
> 3 weeks (n = 44)
P value
Basic demographics
Sex---0.392
Female28 (29.8)13 (26)15 (34.1)-
Male66 (70.2)37 (74)29 (65.9)-
Age, years, mean ± SD52.5 ± 12.954.1 ± 13.350.6 ± 12.40.192
BMI, mean ± SD23.1 ± 3.423.1 ± 3.223.1 ± 3.70.830
CCI, (Q1, Q3)3 (1, 4)2 (1, 4)3 (1, 5)0.163
Laboratory test within 3 days before ERCP
WBC, × 109/L (Q1, Q3)8.2 (6.3, 16.9)8.5 (7.2, 11.6)8.1(6.0, 12.8)0.909
ALT, U/L (Q1, Q3)36.4 (25.9, 80.6)32.3 (25.9, 57.3)38 (24.7, 98.0)0.480
Tbil, μmol/L (Q1, Q3)20.2 (12.3, 38.8)20.5 (13.5, 60.0)18.5 (11.7, 36.5)0.191
Albumin, g/L, mean ± SD35.2 ± 5.935.4 ± 6.835.0 ± 4.80.728
Creatinine, μmol/L (Q1, Q3)58.4 (48.9, 71.7)57.2 (46.6, 71.1)59.2 (46.4, 71.2)0.796
Etiology of BDLs---0.307
Cholecystectomy65 (69.1)39 (78.0)26 (59.1)-
Liver transplantation13 (13.8)6 (12.0)7 (15.9)-
Partial hepatectomy8 (8.5)3 (6.0)5 (11.4)-
Trauma4 (4.3)1 (2.0)3 (6.8)-
Others4 (4.3)1 (2.0)3 (6.8)-
Treatment methods---0.149
Plastic stent52 (55.3)28 (56)32 (64)-
5 Fr2 (2.1)0 (0)2 (4.5)-
7 Fr3 (3.2)3 (6.0)0 (0)-
8.5 Fr12 (12.8)5 (10.0)7 (15.9)-
10 Fr35 (37.2)20 (40.0)23 (52.3)-
Metal stent (10 mm)3 (3.2)2 (4.0)1 (2.3)-
Nasobiliary drainage tube31 (33.0)20 (40.0)11 (25.0)-
Procedure characteristics
Location of BDLs---0.488
Cystic duct53 (56.4)29 (58.0)24 (54.5)-
Common bile duct20 (21.3)10 (20.0)10 (22.7)-
Hilar bile duct12 (12.8)8 (16.0)4 (9.1)-
Intrahepatic bile duct9 (9.6)3 (6.0)6 (13.6)-
Abdominal drainage76 (80.9)42 (84.0)34 (77.3)0.410
Strasberg classification---0.259
A38 (40.4)24 (48.0)14 (31.8)-
C11 (11.7)5 (10.0)6 (13.6)-
D32 (34.0)13 (26.0)19 (43.2)-
E15 (5.3)4 (8.0)1 (2.3)-
E28 (8.5)4 (8.0)4 (9.1)-